The Smart Money Will Pile Into This Top-Performing Sector

[vc_section el_class=”landing_page” css=”.vc_custom_1518629212916{background-color: #e2e2e2 !important;}”][vc_row][vc_column][vc_column_text]

With the largest cannabis market opening up the floodgates of legalization in 2018, the market is ripe for early investors to capitalize.

[/vc_column_text][/vc_column][/vc_row][/vc_section][vc_section el_class=”landing_page” css=”.vc_custom_1521228184794{background-color: #eb9812 !important;}”][vc_row][vc_column][vc_column_text]

Immediately Consider a Position in FinCanna Capital Corp. (CSE: CALI & US: FNNZF).

[/vc_column_text][/vc_column][/vc_row][/vc_section][vc_section el_class=”landing_page”][vc_row][vc_column][vc_column_text]

Dear Reader,

There is a virtue in taking the road less traveled and finding a solution to problems when they exist, rather than throwing your hands up.

The cannabis market is facing a banking crisis.

The problem now is that the federal and state laws are conflicting in regards to cannabis, and because of this, traditional banks are on the sidelines for this industry. Cannabis companies are starving for funds, and for those who are in a position to provide it, these entities could be positioned very favorably.

This VERY fact is what led me to FinCanna Capital Corp., which is currently trading at a very attractive price, in my opinion.

My number one Cannabis Royalty Play for 2018 is FinCanna Capital Corp. (CSE: CALI & US: FNNZF).

After investigating dozens of cannabis companies with profit angles left and right, FinCanna’s royalty model is what caught my eye. What specifically caught my attention is that it is a low-risk revenue model that theoretically has unlimited upside potential. This company was designed to enable both new start-ups and expanding companies to bridge the financing gap that is facing this trend.

Royalty models are extremely strategic and are a win-win for both ends of the partnership.

FinCanna’s Flagship Investment Showcases the Potential

The company has already inked a $14 million deal with one California-based medical cannabis producer to partially finance the development of its new production facility to be constructed in Coachella, California.

What has piqued my interest most about FinCanna is that their flagship investment involves Cultivation Technologies Inc. (CTI), in which CTI will share 50% of the profits that are derived from their interim medical extraction facility that is currently operating in Coachella.

[/vc_column_text][vc_single_image image=”15254″ img_size=”full” alignment=”center”][vc_column_text]Recent changes to the agreement with CTI potentially provide FinCanna with additional revenue during the interim period before CTI’s planned 111,500 square foot, state-of-the-art, licensed facility is developed that will include cultivation, extraction, manufacturing, testing, and distribution.

According to Andriyko Herchak, FinCanna’s CEO: “It’s going to be a dynamic market space. With FinCanna’s royalty model, we should be very well positioned to see new top-tier projects and invest in these projects to the benefit of both FinCanna shareholders and the operators of the projects.”

FinCanna’s exposure to the CTI facility is up to 30,000,000 grams of high-margin raw cannabis oils per annum once its facility is fully built out.[/vc_column_text][vc_column_text css=”.vc_custom_1521227750630{padding-top: 20px !important;padding-bottom: 20px !important;background-color: #e5e5e5 !important;}”]


[/vc_column_text][vc_column_text]Because of its federal classification as a Schedule I substance, cannabis is extremely under-researched globally. The full magnitude of this sector has yet to even be fully understood, and what is coming will be a complete blindside for the sector.

Arcview Market Research predicts that California will see regulated sales grow at a 23.1% annual pace between 2016-2020 as adult use sales come into play. By 2020, the total regulated industry will be worth $6.5 billion.

Just to give you some perspective, the three largest agricultural markets in California include milk and cream ($6.1 billion), grapes ($5.6 billion), and almonds ($5.2 billion). Right now, experts are saying that the current cannabis market, including the black market, is worth about $8.5 billion.

Government is About to Get Addicted

After passing Proposition 64 and legalization of recreational cannabis on January 1, 2018, California has gone on to be the world’s largest regulated market. And the rest of the world follows California.

Government is going to love this industry, especially once it gets hooked…[/vc_column_text][vc_single_image image=”15255″ img_size=”full” alignment=”center”][vc_column_text]FinCanna’s management team is well situated to evaluate and act on new opportunities.

Part of the firm’s strategy is to continually evaluate new projects and expand the firm’s portfolio with promising royalty investments in top-tier companies and projects in the medical cannabis sector.

Investing in FinCanna now is my way to spring-load my portfolio for the future of 21st-century cannabis!

I’m betting big that the convergence of trends is going to greatly benefit FinCanna as the opportunity in the multibillion-dollar medicinal cannabis business explodes.

Political and social beliefs aside, California is ground zero for societal trends that the world comes around to embrace. California is opening people’s eyes to the healing power of cannabis and how it can truly remedy some of the world’s most common ailments.

Focusing on the world’s 6th-largest economy, FinCanna is strategically positioned with a business model that bridges the gap between banks and this smoking sector that is starving for cash.

Cannabis companies are struggling to raise money, and for now, banks have thrown their hands up in defeat. Solutions like what FinCanna is offering are exactly what this sector needs NOW more than ever.

Don’t sit on the fence for too long on this one. Time is of the essence.[/vc_column_text][vc_column_text]Prosperous Regards,
Kenneth Ameduri
Chief Editor,[/vc_column_text][/vc_column][/vc_row][/vc_section][vc_section][vc_row][vc_column][vc_column_text]


Legal Notice:

This work is based on public filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

 Never base any decision off of our advertorials. Crush The Street stock profiles are intended to be stock ideas, NOT recommendations.

The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current public filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the public, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We are long FinCanna Capital Corp. and own shares of the company that we will not sell during our active marketing coverage. The company has paid two hundred and fifty thousand Canadian dollars for one year of digital advertising, which includes emails, videos, and interviews. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say.

Please review our entire disclaimer at